ECG

Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 759.64 M826.63 M921.47 M986.82 M1.01 B 3.75 B Gross profit 86.26 M92.49 M119.87 M124.22 M117.5 M 454.09 M Operating expenses 40.42 M37.52 M46.17 M50.71 M50.06 M 184.46 M Selling/general/admin expenses 40.25 M41.51 M47.36 M51.84 M48.63 M 189.34 M Research & development ————— — Operating income 46.01 M50.98 M72.51 M72.38 M68.88 M 264.75 M Non-Operating Income, Total 1.19 M567 K1.91 M3.75 M1.9 M 8.12 M Interest expense, net of interest capitalized 5.2 M4.69 M4.81 M5.44 M6.5 M 21.45 M Non-Operating Income, excl. Interest Expenses -4.01 M-4.13 M-2.9 M-1.7 M-4.6 M -13.33 M Unusual income/expense ————— — Pretax income 46.38 M50.24 M72.25 M77.59 M73.99 M 274.08 M Equity in earnings 4.39 M3.39 M2.65 M5.54 M4.69 M 16.27 M Taxes 11.92 M13.57 M19.41 M20.62 M18.71 M 72.31 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 34.47 M36.67 M52.84 M56.98 M55.28 M 201.77 M Discontinued operations ————— — Net income 34.47 M36.67 M52.84 M56.98 M55.28 M 201.77 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 34.47 M36.67 M52.84 M56.98 M55.28 M 201.77 M Basic earnings per share (Basic EPS) 0.680.721.041.121.07 3.95 Diluted earnings per share (Diluted EPS) 0.680.721.031.111.09 3.95 Average basic shares outstanding 50.97 M51.04 M51.04 M51.05 M51.05 M 204.18 M Diluted shares outstanding 51.07 M51.09 M51.09 M51.14 M51.12 M 204.44 M EBITDA 54.41 M62.25 M81.34 M81.31 M75.44 M 300.35 M EBIT 45.84 M54.97 M73.7 M73.51 M67.44 M 269.63 M Cost of revenue 673.38 M734.14 M801.6 M862.6 M893.97 M 3.29 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 8.57 M7.28 M7.64 M7.8 M8 M 30.72 M